BriaCell Therapeutics Corp. (BCTX)
BriaCell Therapeutics Corp. (BCTX)
| Balance Sheets | 2026-04-30 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Cash and cash equivalents | 6,880,221 | 2,714,012 | 10,493,808 | |
| Short-term investments | 15,924,204 | 7,461,960 | 7,372,473 | |
| Amounts receivable and prepaid expenses | 2,588,749 | 1,172,435 | 2,060,295 | |
| Total current assets | 25,393,174 | 11,348,407 | 19,926,576 | |
| Equity investment in bc therapeutics | 750,982 | 554,448 | 524,278 | |
| Intangible assets, net | 173,072 | 180,707 | 184,525 | |
| Property and equipment, net | 348,997 | 273,980 | 296,819 | |
| Long term prepaid expenses | 405,085 | 717,508 | 717,508 | |
| Total non-current assets | 1,678,136 | 1,726,643 | 1,723,130 | |
| Total assets | 27,071,310 | 13,075,050 | 21,649,706 | |
| Trade payables | 2,174,437 | 2,128,915 | 3,283,703 | |
| Accrued expenses and other payables | 1,416,059 | 1,188,858 | 694,285 | |
| Total current liabilities | 3,590,496 | 3,317,773 | 3,977,988 | |
| Warrant liability | 71,854 | 406,873 | 337,672 | |
| Total non-current liabilities | 71,854 | 406,873 | 337,672 | |
| Share capital of no par value authorized unlimited at april 30, 2026 and july 31, 2025 issued and outstanding 7,250,487 shares at april 30, 2026 and 1,883,906 july 31, 2025, respectively | 117,117,225 | 101,739,923 | 101,739,923 | |
| Share-based payment reserved | 11,202,809 | 10,610,826 | 10,316,140 | |
| Warrant reserve | 30,216,165 | 17,719,026 | 17,719,026 | |
| Accumulated other comprehensive loss | -138,684 | -138,684 | -138,684 | |
| Non-controlling interest | -649,099 | -627,558 | -546,795 | |
| Accumulated deficit | -134,339,456 | -119,953,129 | -111,755,564 | |
| Total shareholders equity | 23,408,960 | 9,350,404 | 17,334,046 | |
| Total liabilities and shareholders equity | 27,071,310 | 13,075,050 | 21,649,706 | |